Drug General Information |
Drug ID |
D08JCU
|
Former ID |
DNC007934
|
Drug Name |
(E)-2-(4-fluorostyryl)-5-(phenylsulfinyl)pyridine
|
Drug Type |
Small molecular drug
|
Indication |
Discovery agent
|
Investigative |
[1]
|
Structure |
|
Download
2D MOL
3D MOL
|
Formula |
C19H14FNOS
|
Canonical SMILES |
C1=CC=C(C=C1)S(=O)C2=CN=C(C=C2)C=CC3=CC=C(C=C3)F
|
InChI |
1S/C19H14FNOS/c20-16-9-6-15(7-10-16)8-11-17-12-13-19(14-21-17)23(22)18-4-2-1-3-5-18/h1-14H/b11-8+
|
InChIKey |
YFWOOEBYKGJCJO-DHZHZOJOSA-N
|
PubChem Compound ID |
|
Target and Pathway |
Target(s) |
Potassium voltage-gated channel subfamily H member 2 |
Target Info |
Inhibitor |
[1]
|
5-hydroxytryptamine 2A receptor |
Target Info |
Inhibitor |
[1]
|
5-hydroxytryptamine 2C receptor |
Target Info |
Inhibitor |
[1]
|
KEGG Pathway
|
Calcium signaling pathway
|
Neuroactive ligand-receptor interaction
|
Gap junction
|
Serotonergic synapse
|
Inflammatory mediator regulation of TRP channelshsa04020:Calcium signaling pathway
|
Inflammatory mediator regulation of TRP channels
|
PANTHER Pathway
|
5HT2 type receptor mediated signaling pathwayP04374:5HT2 type receptor mediated signaling pathway
|
PathWhiz Pathway
|
Muscle/Heart Contraction
|
Reactome
|
Voltage gated Potassium channelsR-HSA-390666:Serotonin receptors
|
G alpha (q) signalling eventsR-HSA-390666:Serotonin receptors
|
G alpha (q) signalling events
|
WikiPathways
|
SIDS Susceptibility Pathways
|
Hematopoietic Stem Cell Differentiation
|
Potassium ChannelsWP733:Serotonin Receptor 2 and STAT3 Signaling
|
Serotonin Receptor 2 and ELK-SRF/GATA4 signaling
|
Monoamine GPCRs
|
GPCRs, Class A Rhodopsin-like
|
Gastrin-CREB signalling pathway via PKC and MAPK
|
GPCR ligand binding
|
GPCR downstream signaling
|
GPCRs, OtherWP732:Serotonin Receptor 2 and ELK-SRF/GATA4 signaling
|
References |
REF 1 | Bioorg Med Chem Lett. 2007 May 1;17(9):2643-8. Epub 2007 Feb 2.2,5-Disubstituted pyridines: the discovery of a novel series of 5-HT2A ligands. |